Insmed INC Form 4 insider transactions

Martina Flammer, Chief Medical Officer of Insmed Inc., sold shares of common stock to satisfy tax withholding obligations and cover broker fees.

Insmed's Chief Financial Officer, Sara Bonstein, sold shares of common stock to cover tax withholding obligations and broker fees related to the vesting of Restricted Stock Units.

Insmed Inc.'s Chief Operating Officer, Roger Adsett, sold shares of common stock to cover tax withholding obligations and broker fees related to the vesting of Restricted Stock Units.

Director Melvin Sharoky reports a gift of Insmed Inc. common stock and updates to beneficial ownership, including holdings through family trusts and LLCs.

Insmed's CEO, William Lewis, exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan, while also reporting holdings through family trusts.

Insmed Inc. CEO William Lewis exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.

William Lewis, Chair and CEO of Insmed Inc, reports the sale of common stock and exercise of stock options on April 1, 2025, according to a pre-arranged 10b5-1 trading plan.

Insmed's CEO, William Lewis, exercised stock options and sold shares of common stock on March 17, 2025, under a pre-arranged 10b5-1 trading plan.

Insmed's CEO, William Lewis, exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan on March 3, 2025.

Director Melvin Sharoky reports changes in beneficial ownership of Insmed Inc. stock due to gifts.

Insmed's Chair and CEO, William Lewis, executed stock sales under a pre-arranged 10b5-1 trading plan and transferred a significant portion of his holdings to his ex-spouse as part of a divorce settlement.

Insmed's Chief Financial Officer, Sara Bonstein, executed sales of common stock on February 18, 2025, under a pre-arranged 10b5-1 trading plan.

Sara Bonstein, CFO of Insmed Inc., sold shares of common stock on February 11 and 12, 2025, according to a Form 4 filing with the SEC.

Insmed Inc.'s Chief Operating Officer, Roger Adsett, executed multiple sales of common stock on February 10, 2025, under a pre-arranged 10b5-1 trading plan.

Martina Flammer, Chief Medical Officer of Insmed Inc., executed multiple sales of common stock on February 10, 2025, under a pre-arranged 10b5-1 trading plan.

Martina Flammer, Chief Medical Officer of Insmed Inc., reports the acquisition of shares through vested Performance Stock Units (PSUs) and subsequent sale of shares to cover tax obligations.

Insmed's Chief People Strategy Officer, S. Nicole Schaeffer, sold 23,500 shares to cover tax obligations after the vesting of Performance Stock Units.

Chief Operating Officer Roger Adsett reports acquisition and disposal of Insmed Inc. common stock related to the vesting of Performance Stock Units (PSUs) and subsequent sales to cover tax obligations.

Insmed's CEO, William Lewis, reports acquiring shares through vested Performance Stock Units (PSUs) and subsequently selling a portion to cover tax obligations.

Chief Commercial Officer John Drayton Wise reports acquisition of shares through vesting of Performance Stock Units and subsequent sales to cover tax obligations.

Insmed's CFO, Sara Bonstein, reports acquiring shares through vested Performance Stock Units (PSUs) and subsequently selling a portion to cover tax obligations.

Chief Legal Officer Michael Smith reports acquisition of shares through vesting of Performance Stock Units and subsequent sale to cover tax obligations.

Insmed's CEO, William Lewis, exercised stock options and sold shares of common stock on February 3, 2025, under a pre-arranged 10b5-1 trading plan.

S. Nicole Schaeffer, Chief People Strategy Officer at Insmed Inc., reports the exercise of stock options and subsequent sale of shares under a pre-arranged 10b5-1 trading plan.

Martina Flammer, Chief Medical Officer of Insmed Inc., sold 1,384 shares of common stock at $68.72 per share on January 14, 2025, under a pre-arranged 10b5-1 trading plan.

Insmed Inc.'s Chief Operating Officer, Roger Adsett, sold 1,457 shares of common stock at $68.72 per share under a pre-arranged 10b5-1 trading plan.

Insmed Inc.'s Chief People Strategy Officer, S. Nicole Schaeffer, sold 872 shares of common stock at $68.72 per share under a pre-arranged 10b5-1 trading plan.

Insmed's CEO, William Lewis, engaged in multiple stock transactions, including option exercises and sales, under a pre-arranged 10b5-1 trading plan.

Insmed Inc.'s Chief Medical Officer, Martina Flammer, reported multiple transactions involving the company's common stock and stock options, including sales to cover tax obligations and the vesting of restricted stock units.

Insmed's Chief Financial Officer, Sara Bonstein, has reported multiple transactions involving the company's stock, including sales to cover tax obligations and the acquisition of restricted stock units and stock options.